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SUMMARY
In this paper, we extend the definitions of the net reclassification improvement (NRI) and the integrated
discrimination improvement (IDI) in the context of multicategory classification. Both measures were pro-
posed in Pencina and others (2008. Evaluating the added predictive ability of a new marker: from area under
the receiver operating characteristic (ROC) curve to reclassification and beyond. Statistics in Medicine
27, 157–172) as numeric characterizations of accuracy improvement for binary diagnostic tests and were
shown to have certain advantage over analyses based on ROC curves or other regression approaches. Esti-
mation and inference procedures for the multiclass NRI and IDI are provided in this paper along with
necessary asymptotic distributional results. Simulations are conducted to study the finite-sample proper-
ties of the proposed estimators. Two medical examples are considered to illustrate our methodology.
Keywords: Area under the ROC curve; Integrated discrimination improvement; Multicategory classification; Multi-
nomial logistic regression; Net reclassification improvement.
1. INTRODUCTION
Diagnostic and classification tasks are encountered in medical practice where we need to accurately dif-
ferentiate the disease-present and the disease-absent status of a patient. Sometimes the classification may
involve more than two categories which need to be treated separately. For example, one of the motivating
examples of this paper is a classification for synovitis where patients from five distinct disease categories
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are examined, each requiring a different patient management strategy. Health-care procedures are decided
based on the determination of the most likely status of the patient. Biomarkers are often used to predict
the patient’s disease status, drawing upon a set of well-established statistical tools for evaluating diagnostic
accuracy.
Typically, in binary classification, one employs statistical methods based on the receiver operating char-
acteristic (ROC) analysis and provides the estimated ROC graph and/or summary measures of the ROC
graph such as the area under the curve (AUC) or the partial AUC (Zhou and others, 2002). Such meth-
ods vary the threshold used to classify individuals as diseased and non-diseased and then combines the
resulting sensitivities and specificities across all possible thresholds. The extensions of these methods to
multicategory classification have been recently proposed. Specifically, we may use the hypervolume under
the multidimensional ROC manifold (HUM) as an extension of the AUC to evaluate the classification accu-
racy for any biomarker in a multiclass problem (Mossman, 1999). The HUM has an interpretation akin to
the AUC where a large HUM value indicates a high classification accuracy. The inference procedure for
the HUM has been discussed in Nakas and Yiannoutsos (2004) for ordered polychotomous responses and
Li and Fine (2008) for unordered polychotomous responses. Shiu and Gatsonis (2012) provides a review
of ROC-type methods for multiclass problems.
While ROC-based measures have been widely adopted, it has been argued by many authors
(Pepe and others, 2004; Pencina and others, 2008) that such measures may not be good criteria to quan-
tify improvements in diagnostic accuracy when the added value of a new predictor to an existing model
is of interest. Such analyses are critically important in the development of predictive models based on
biomarkers, where the added value of markers which may be expensive to obtain must be weighed against
the associated financial costs. The interpretation of the AUC provides an indirect assessment of the pre-
dictive performance of a model. Thus, the gain with a new predictor may be unclear. A related issue is
that the AUC measures may be relatively insensitive to the addition of predictors in certain regions of the
AUC space. To address these limitations, Pencina and others (2008) proposed two novel criteria based on
reclassification in order to directly quantify the extent to which a new predictor improves classification
performance: the net reclassification improvement (NRI) and the integrated discrimination improvement
(IDI). These measures have met with widespread success in the medical literature, with many practition-
ers preferring their ease of interpretation versus ROC-based measures. For additional discussion of these
recent developments, we refer the reader to Pencina and others (2011, 2012).
In this paper, we extend the reclassification indices to multicategory classification problems, providing
an alternative to HUM-based analyses. The multicategory definitions of the NRI and the IDI are presented
in Section 2.1, with their inferential procedures described in Section 2.2. The use of such measures in
model building is discussed in Section 2.3, with an eye toward high-dimensional data structures, where
the number of predictors may be much larger than the sample size. Extensive numerical studies are con-
ducted. Simulations are reported in Section 3, with two real data examples presented in Section 4, including
the synovitis example mentioned previously and a microarray example, where it is important to select a
small number of the most important expression biomarkers for the prediction of cancer (Li and Fine, 2008;
Ma and Song, 2011, among others).
2. METHODS
2.1 Accuracy parameters
Consider a set of predictors  = {X1, . . . , X p}. Suppose that we have a sample of subjects with measure-
ments of all X j ( j = 1, . . . , p). The goal is to use them to construct a meaningful statistical model for
predicting the multicategory outcome Y which takes values from Y = {1, 2, . . . , M}. We define the binary
random variable Ym = I (Y = m) and let the prevalence for the mth category be ρm = E(Ym) = P(Y = m).
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Suppose that a model M1 is constructed based on a set of predictors 1 ⊂ . Such a model M1 can
generate a probability vector p(M1) = (p1(M1), . . . , pM(M1)) for each subject where ∑Mm=1 pm(M1)= 1. Decision makers may assign a subject to one of the M categories according to the greatest component
in the probability vector. One may quantify the accuracy ofM1 based on 1 by the following multicategory





where each CCPm is the CCP for the mth-category. For the model M1, we write
CCPm(M1) = P{pm(M1) = max p(M1) | Y = m}, m = 1, . . . , M. (2.2)
Now suppose that more variable(s) are included and we construct a model M2 that is based on a set of
predictors 2 ⊃ 1. We use the nested-structure notations as they are widely discussed in the literature.
We note that there are plenty of cases where the accuracy improvement occurs among non-nested models.
Our proposed methods can apply with slight modification.
The newly constructed model M2 generates another probability vector p(M2) = (p1(M2), . . . ,
pM(M2)) for each subject where
∑M
m=1 pm(M2) = 1. Again, decision makers may assign the subject
according to the greatest value of this probability vector, and the mth-category accuracy of M2 based on
2 can be quantified by
CCPm(M2) = P{pm(M2) = max p(M2)|Y = m}, m = 1, . . . , M. (2.3)




wm{CCPm(M2) − CCPm(M1)}, (2.4)
where wm are positive weights for the mth category. When M = 2, the two CCPs are usually called the
sensitivity and specificity of the model-based test. The T measure thus quantifies the overall increase of
the weighted sum of sensitivity and specificity. When equal weights are used for the two categories, T is
simply the difference of Youden’s index between the two models. We shall call (2.4) the reclassification
improvement (RI) since it reflects how the accuracy changes after a reclassification.
The RI measure has well-known limitations in assessing improvements in diagnostic accuracy and has
not been widely adopted in practice (Pencina and others, 2008). Here, we propose to extend the NRI, which
has recently been studied as an alternative to the RI for binary classification. The multicategory extension




wm P{pm(M2) = max p(M2), pm(M1) = max p(M1)|Y = m}. (2.5)
When M = 2 and wm = 12 , S is equivalent to the NRI given in Pencina and others (2008). We refer to
S as the NRI in this article since it indicates the probability that added markers in M2 lead to correct
classification of subjects who are incorrectly classified using the smaller model M1. We note that, in the
two-category classification, the decision can be based on whether the class probability exceeds 12 with
equal priors on the two categories.
The IDI can be generalized to multiple categories by noticing the connection between the IDI in binary
classification problems and R2 (Cox and Wermuth, 1992; Menard, 2000; Tjur, 2009). The interpretation
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and computation of R2, also called a coefficient of determination, has been discussed for binary logistic
regression models. Simply speaking, the value of R2 is the fraction of the total variation explained by the
model. For linear regression models, R2 is closely related to the correlation coefficient and the ANOVA
F-test, while for binary regression, it is closely connected to the probabilities of correct classification.
Let R2(M j ) = (R21(M j ), . . . , R2M(M j )) be an M-dimensional vector with
R2m(M j ) =
var(Ym) − E{var(Ym |M j )}
var(Ym)
= var{pm(M j )}
ρm(1 − ρm) . (2.6)
The second equality follows because E(Ym |M j ) = pm(M j ). It has been shown in Pepe and others (2008)
that the increase in R2 for binary classification (M = 2) from model M1 to model M2 is equivalent to the





wm{R2m(M2) − R2m(M1)}. (2.7)
We refer to (2.7) as the IDI in this paper, similarly to the binary case. The multicategory IDI (2.7) reduces
to that in Pencina and others (2008) when M = 2 and equal weights w1 = w2 = 12 are used.
The choice of weights in the definitions of the NRI and the IDI may depend on the goal and design of
the study. When aiming for the overall test accuracy to differentiate multiple classes, it is natural to weigh
all categories equally; on the other hand, as pointed out in Pencina and others (2011), sometimes it is useful
to reward some categories with higher weights when savings associated with correct classification of such
categories outweigh other categories. When cost-efficiency information is available, we can incorporate
them easily in the inference for the weighted NRI and IDI. There are also other practical considerations
that invoke unequal weights and one can run a Bayesian prior elicitation procedure to construct reasonable
weights (Li and Fine, 2010).
2.2 Estimation theory
Suppose we obtain a sample {Xi1, . . . , Xip, Yi : i = 1, . . . , n}. We denote the class sample size nm =∑n
i=1 I (Yi = m) for the mth category. We assume that n → ∞ and nm/n → ρm > 0 for all m. One may fit
the candidate models M1 and M2 from the preceding subsection using one’s method of choice. The main
requirement is that the method provide estimated probability assessment vectors for each model. Using








{I ( p̂mi (M2) = max p̂i (M2), Yi = m)









I { p̂mi (M2) = max p̂i (M2), p̂mi (M1) = max p̂i (M1), Yi = m}, (2.9)
where p̂i (M j ) = ( p̂1i (M j ), p̂2i (M j ), . . . , p̂Mi (M j )) is the estimated membership probability for the
i th subject based on the j th model. In practice, they can be obtained from fitting a multinomial logistic
regression model to the data and then outputting the predicted probabilities from the fitted model. We note
that when the models are consistently estimated, p̂i (M j ) is consistent to pi (M j ) and therefore, by the law
of large numbers, T̂ and Ŝ are consistent to T and S, respectively. Furthermore, by using the central limit
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theorem, we can show that
√











wiw j (ai − bi )(a j − b j ), (2.10)
with am = CCPm(M1), bm = CCPm(M2), cm = P(pm(M1) = max p(M1), pm(M2) = max p(M2)|Y =
m), and
√











wiw j di d j , (2.11)
with dm = P(pm(M1) = max p(M1), pm(M2) = max p(M2)|Y = m). We note that the terms following∑n
i=1 in Ŝ and Ŝ are not independent. We obtain independent sums only after changing the order of sum-
mation and then are able to apply the central limit theorem. In practice, all the components involved in the
variance expressions can be consistently estimated by plugging in the sample version of the probabilities.








{[ p̂mi (M2) − p̂m(M2)]2 − [ p̂mi (M1) − p̂m(M1)]2}, (2.12)
where p̂m(M j ) = n−1 ∑ni=1 p̂mi (M j ).
We can also show that (2.12) is consistent to R for a large n by noting that, for a large sample, p̂mi (M j )
is consistent to pmi (M j ), and the average squared distance to the mean n−1
∑n
i=1{ p̂mi (M2) − p̂m(M2)}2
is consistent to var{pm(M j )}. The consistency then follows from the law of large numbers. As with RI
and NRI, one may further show that
√







ρ jρk(1 − ρ j )(1 − ρk) {E[((p j (M1) − μ j (M1))
2 − (p j (M2) − μ j (M2))2)
× ((pk(M1) − μk(M1))2 − (pk(M2) − μk(M2))2)] − E[(p j (M1) − μ j (M1))2 − (p j (M2)
− μ j (M2))2]E[(pk(M1) − μk(M1))2 − (pk(M2) − μk(M2))2]}, (2.13)
and μm(M j ) = E(pm(M j )). All the moments involved in the variance expression can be readily estimated
by using empirical moment estimators. The variance can then be estimated by the plug-in method.
The above parameter estimation and variance estimation formula are implemented in the software R
and the code is downloadable at http://www.stat.nus.edu.sg/∼stalj. Although the variance formula (2.11)
and (2.13) look complicated in the above presentation, our experiences with simulation and real data anal-
ysis suggest that they can be evaluated instantly following the point estimation by using our code. These
formula allow inferences to be carried out much faster than a resampling-based approach. An advantage
of the resampling method is that the sampling variability in the estimation of the probability vector may
be formally accounted for in the inference.
2.3 Model-building procedure
For biomedical data with ever-growing dimensionality and complexity, we often face the challenge p  n
and cannot afford using all p markers for the construction of a feasible prediction model. We now propose a
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procedure to select important predictors for regression analysis with multicategory response. Specifically,
we adopt a forward selection algorithm by using the NRI and the IDI as the selection criteria. The model-
building algorithms are similar for the two criteria. We thus choose to present the detailed procedure for
the NRI only.
We start with a null model. At the first step, we fit regression models with a single covariate for all X j
j = 1, . . . , p and evaluate the NRI for each X j . The variable that gives the highest NRI value is chosen at
this stage. At the second step, we fit regression models with the previously selected predictor and another
predictor in the remaining set. We evaluate the NRI again for each model and then select the best model
according to the highest NRI. The selection procedure proceeds until a stopping rule is satisfied.
We consider two stopping rules in this paper. Rule I stops the model-building procedure when a pre-
specified number of predictors or pre-specified proportion of all predictors is achieved. Rule II stops the
model-building procedure when a pre-specified full-model accuracy is achieved, for example, 90% of the
overall CCP. When resources are limited and only a fixed number of markers can be fully investigated in
a study, we may consider Rule I and retain a relatively parsimonious model; on the other hand, when there
is sufficient support that allows us to examine as many markers as possible, we may target a very high
accuracy and choose Rule II. As demonstrated in the microarray analysis in Section 4.2, it may be possible
to achieve 100% accuracy in some applications. Simulation studies included in supplementary material
available at Biostatistics online find satisfactory performance of this forward selection method.
3. SIMULATION ANALYSIS OF ESTIMATION CONSISTENCY
In this section, we used simulation studies to examine the performance of our proposed estimators Ŝ and
R̂ for the NRI and the IDI, respectively. We consider six different scenarios.




= −0.5 + 1.5X1 + 3X2, log p3
p1
= −1 + 2X1 + 4X2,
where p j = P(Y = j) for j = 1, 2, 3. We generate (X1, X2) from a multivariate normal distribution with
mean (1, 1) and covariance matrix  = (σi, j )1i, j2. We let σ11 = σ22 = 1, and σ12 = σ21 = 0 and let
M1 = {X1}, M2 = {X1, X2}.
Case 2. The same as Case 1 except that we let σ12 = σ21 = 0.2.









= −4 + 2.5X1 + 2.25X2 + 2X3 + 1.75X2 + 1.5X1.
We generate (X1, X2, . . . , X5) from a multivariate normal distribution with mean (1, 1, 1, 1, 1)
and covariance matrix  = (σi, j )1i, j5. We set  = diag{1, 1, 1, 1, 1} and let M1 = {X1}, M2 =
{X1, X2, X3, X4, X5}.
Case 4. The same as Case 3 except that we let σi j = 0.1, i = j . This imposes a compound symmetry
dependence structure for the covariates.
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Table 1. Performance of Ŝ and R̂ over 1000 simulations
S Avg.SDS Ŝ SEŜ CRS R Avg.SDR R̂ SER̂ CRR
Case 1
n = 150 0.263 0.067 0.271 0.055 0.977 0.263 0.053 0.279 0.052 0.925
n = 300 0.263 0.047 0.269 0.040 0.973 0.263 0.036 0.272 0.036 0.937
Case 2
n = 150 0.238 0.059 0.246 0.057 0.955 0.252 0.049 0.262 0.050 0.935
n = 300 0.238 0.042 0.246 0.041 0.952 0.252 0.034 0.258 0.034 0.951
Case 3
n = 150 0.282 0.094 0.322 0.076 0.977 0.319 0.088 0.385 0.085 0.938
n = 300 0.282 0.062 0.298 0.051 0.977 0.319 0.054 0.346 0.052 0.946
Case 4
n = 150 0.302 0.083 0.317 0.071 0.976 0.334 0.076 0.384 0.077 0.930
n = 300 0.302 0.056 0.305 0.048 0.969 0.334 0.049 0.356 0.049 0.944
Case 5
n = 150 0.226 0.057 0.251 0.046 0.975 0.178 0.039 0.203 0.038 0.922
n = 300 0.226 0.039 0.237 0.032 0.975 0.178 0.025 0.186 0.024 0.942
Case 6
n = 150 0.223 0.053 0.249 0.046 0.953 0.183 0.036 0.206 0.036 0.900
n = 300 0.223 0.037 0.238 0.033 0.957 0.183 0.024 0.194 0.024 0.939
S and R are the true value of NRI and IDI computed using Monte Carlo; avg.SDS and avg.SDR are mean of estimated SEs of Ŝ and
R̂ computed based on (2.11) and (2.13) over 1000 simulations; Ŝ and SEŜ are the mean and standard deviation of the estimated NRI
over 1000 simulations; R̂ and SER̂ are the mean and standard deviation of the estimated IDI over 1000 simulations; CRS = (number
of simulations the true NRI falling into the interval [Ŝ − 1.96SEŜ, Ŝ + 1.96SEŜ])/1000; CRR = (number of times the simulations
the true IDI falling into the interval [R̂ − 1.96SER̂ , R̂ + 1.96SER̂])/1000.




= −4 + 3X1 + 3.5X2 + 4X3 log p3
p1




= −2 + 2X1 + 2.5X2 + 3X3 log p5
p1
= −1 + 1.5X1 + 2X2 + 2.5X3.
We generate (X1, X2, X3) from a multivariate normal distribution with mean (1, 1, 1) and covariance
matrix  = diag(1, 1, 1), M1 = {X1},M2 = {X1, X2, X3}.
Case 6. The same as Case 5 except that we set σ12 = σ21 = σ23 = σ32 = 0.1.
For each case, we simulated 1000 data sets and carried out the estimation procedures for the NRI and
the IDI introduced in the previous section. The numerical results are summarized in Table 1. Eyeballing
Table 1, we notice that both Ŝ and R̂ perform very well in estimating S and R, respectively, in all cases.
The variance formula for the NRI and the IDI also provide very close approximation to the sampling vari-
ability of the estimators. The coverage rates are close to 95% and improve as the sample size increases.
We note that in some cases the coverage of the IDI is slightly lower than the nominal level. The undercov-
erage issue may be caused by the fact that we do not account for the sampling variability of the regression
estimation. Another factor is that normal approximation is not appropriate when the IDI is close to zero.
After acknowledging the estimation uncertainty, Kerr and others (2011) derived an approximate χ2 distri-
bution under the null for the two-category classification. Another alternative approach is to consider the
bootstrap.
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4. EXAMPLES
We first consider a medical study with five categories to illustrate the applications of the NRI and the IDI
for a practical assessment of accuracy improvement. A second analysis utilizes data from a genetic study to
demonstrate how the NRI and the IDI can be used for variable selection in high-dimensional data analysis.
Since the HUM has previously been employed for model selection in multicategory set-ups, we explicitly
compare the HUM to the new measures, with a focus on interpretation and model selection issues.
4.1 Tissue biomarkers of synovitis
Synovitis is the inflammation of the synovial membrane and may occur in association with arthritis as well
as lupus, gout, and other conditions. Krenn and others (2006) and Slansky and others (2010) described
a scoring approach to evaluate the grading of the histological severity of synovitis. In their data set, the
primary classification outcome involved five different categories: normal healthy control; Post-traumatic
Arthropathy (PtA); Osteoarthritis (OA); Psoriatic Arthritis (PsA); Rheumatoid Arthritis (RA). The sample
included a total of 583 synovial tissue specimens taken from 33 normal, 29 PtA, 221 OA, 42 PsA, and 341
RA subjects, respectively. Details of the sample collection procedures were included in earlier publications
(Krenn and others, 2006; Slansky and others, 2010).
Three biological measurements are commonly used to predict the patient disease status: the lining
thickness, the inflammatory infiltrates, and the stromal density. Each of the three biomarker components
was graded on a scale from zero to three in the sample. The accuracy of the three biomarkers for pair-
wise binary classification and five-category classification were reported in Krenn and others (2006) and
Slansky and others (2010). We use our proposed approach to evaluate the relative improvement for increas-
ing the marker numbers in a statistical model. For the ease of presentation and comparison, we denoted the
lining thickness as X1, the stromal density as X2, and the inflammatory infiltrates as X3 in this paper. We
first quantified the diagnostic accuracy for each component and then combined them with the multinomial
logistic regression to further improve the diagnostic accuracy.
The estimated NRI and IDI are reported in Table 2. The models with a single covariate are not nested
and cannot be compared using the NRI and the IDI. Instead, we report their CCP in the NRI column and
their R2 values in the IDI column. The second marker X2 has the highest CCP and IDI and is considered
as the most accurate one. The CCP indicates that over 65% of the sample were correctly classified by
X2, while the IDI indicates that approximately 12% of the overall variability of the five-category response
may be attributed to X1. The other two markers have relatively inferior performance, with X3 being the
next most accurate marker and followed by X1. This finding is consistent to the previous observations in
Slansky and others (2010) using ROC-based diagnostic accuracy measures, with the estimated HUMs for
X1, X2, and X3 being 0.0005, 0.0140, and 0.0075, respectively.
It is of interest to combine X2 with other marker(s) to improve the overall diagnostic accuracy. NRI
results suggest that a two-marker model combining X2 with X3 (NRI = 0.0385) may result in a larger
improvement in classification accuracy than with X1 (NRI = 0.0030). The NRI values indicate that the
improvement on a model-based net reclassification rate due to including X3 is more than 10 times of
that due to including X1. We note that marker X3 has the second highest CCP 0.5866 in the one-marker
model. The standard errors (SEs) in the brackets allow us to construct the Wald-type tests. In this case, it
seems that the NRI improvement for the addition of X3 is highly significant, whereas that for adding X1
is not.
On the other hand, IDI results show a similar preference for X3. The IDI improvement for including
X3 (IDI = 0.0302) is three times of that for including X1 (IDI = 0.0102), indicating that the addition of
X3 could explain much more variability in the response. Using the SEs, we carried out the Wald tests and
found that both IDI increases were significantly different from zero.
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Table 2. Estimated NRI and IDI and SEs for three synovitis biomarkers: lining
thickness (X1), stromal density (X2), and inflammatory infiltrates (X3)
Model(s) NRI (SE) IDI (SE)
X1 0.5746 (0.0081) 0.0555 (0.0168)
X2 0.6518 (0.0078) 0.1174 (0.0304)
X3 0.5866 (0.0085) 0.0751 (0.0180)
X1 + X2 versus X2 0.0030 (0.0017) 0.0102 (0.0021)
X3 + X2 versus X2 0.0385 (0.0056) 0.0302 (0.0024)
X1 + X2 + X3 versus X2 + X3 0.0013 (0.0009) 0.0062 (0.0015)
For models with only one marker, NRI is the overall model CCP and IDI is the model R2. For
others, NRI is the NRI value and IDI is the increase in IDI for the two nested models (X3).
In practice, the final model including three markers is always considered as it yields the highest CCP
and IDI. Moving from model {X2 + X3} to model {X1 + X2 + X3}, the NRI is not significant (Wald test
|0.0013/0.0009| < 1.96), while the IDI is highly significant (Wald test |0.0062/0.0015| > 1.96). These
divergent results require careful interpretation because the two measures need to be construed from dif-
ferent perspectives. Adding X1 in the last stage may not significantly improve the number of correct clas-
sifications from the previous model. However, it may still contribute a significant amount of information
and help explain the overall variability of the response.
The results in Table 2 are interesting to investigators as how the model accuracy evolved with the added
complexity was clearly presented and the relative contribution of each marker to the overall classification
was fully demonstrated. The earlier findings in Slansky and others (2010) reported the accuracy for indi-
vidual markers (in the absence of information from other markers) but failed to inform the added accuracy
of new markers in the presence of other already selected marker(s).
4.2 Leukemia classification
We next consider data from leukemia patients used in Golub and others (1999). The data are from a study
of gene expression in three types of acute leukemias, acute lymphoblastic leukemia arising from T-cells
(ALL T-cell), ALL arising from B-cells (ALL B-cell), and acute myeloid leukemia (AML). The data set
contains 8 ALL T-cell samples, 19 ALL B-cell samples, and 11 AML samples. Each sample contains 7912
gene expression values obtained from Affymetrix high-density oligonucleotide microarrays. Our data set
is downloaded from
http://www.broad.mit.edu/cgi-bin/cancer/datasets.cgi.
We consider evaluating the accuracy of the biomarkers for their ability to differentiate the three classes.
The single gene that gives the highest CCP is the 1184th gene in the data file, with a CCP value 0.8421.
We then use the methods in this paper to select a second gene which maximizes the accuracy improvement.
By using the NRI, the best gene is the 2216th gene with an NRI value 0.2145 and SE 0.0678 (P-value
0.0015). Adding the 2216th gene could correctly identify about 20% of the observations that cannot be
correctly classified by using only the 1184th gene. In fact, with these two genes, we reach a 100% overall
CCP value and obtain a perfect classification for the three categories. The empirical distribution of all NRI
values is shown in the left panel of Figure 1. The mode of the distribution is around 0.05, indicating a 5%
improvement over the existing marker.
We have used the IDI for this data set and obtained the same results. At the first step, the 1184th
gene was selected with the highest IDI 0.6364, while at the second step the 2216th genes was added for
providing the most IDI increase 0.3906 (SE 0.0696). No further improvement in the IDI can be attained





































Fig. 1. Empirical distribution of NRI and IDI values for all gene expressions of the Leukemia example.
with additional genes. The empirical distribution of all IDI values is shown in the right panel of Figure 1.
The distribution for the IDI is more skewed than that for the NRI.
Many authors examined this data set using various classification methods such as machine learn-
ing (Golub and others, 1999; Furey and others, 2000; Guyon and others, 2002), threshold circuits
(Albrecht and others, 2003), rigid regression (Li and Yang, 2005), and stochastic search (Albrecht, 2007).
The numbers of gene expression levels used in their studies were all greater than 2. The most similar
previous results may be found in Li and Yang (2005) and Albrecht (2007), where only three genes were
needed to achieve the same accuracy. Our findings based on NRI and IDI selection appear to be a further
improvement from the existing analyses.
We may further use this example to compare across different methods. Besides the NRI and the IDI, a
common ROC-based measure for multicategory classification is the HUM (Li and Fine, 2008). The results
of using the HUM are the same as those obtained as using the NRI and the IDI: selecting the 1184th gene
with the highest HUM value 0.8116 at the first step, and selecting the 2216th gene with the highest HUM
improvement at the second step. This results in the same two genes being selected (in the same order) to
give a 100% HUM in the final model. However, in general the agreement between the three approaches
varies because they focus on different aspects of the model accuracy. The sample correlation coefficient
between the NRI and the IDI values at the second selection step was 0.747. The scatter plot of the IDI versus
the NRI is given in the upper left panel of Figure 2, displaying an increasing association. The correlation
between HUM and NRI was only 0.627 and the scatter plot of HUM versus NRI is given in the upper right
panel of Figure 2. The correlation between HUM and IDI was 0.859, showing a strong dependence pattern
in the lower panel of Figure 2. All correlations are positive and strong, exceeding 0.60, with the association
between IDI and HUM suggesting that, at least in this example these measures provide the most similar
assessment of improvements in leukemia classification accuracy.
5. DISCUSSION
While in the numerical studies, multinomial logistic regression was employed for constructing the prob-
ability assessment, in practice, any procedure providing such assessments could be used. The simplicity
of the logistic analysis is appealing and is theoretically supported by the recent work of Delaigle and Hall
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Fig. 2. Scatterplots of IDI versus NRI, NRI versus HUM and IDI versus HUM for gene expressions in the leukemia
example.
(2012), who established that optimal classification can be achieved with a linear method for Gaussian data.
Considering that normal distribution is perhaps the most prevalent for discrimination and classification
(Pencina and others, 2012), the linear combination approach, thus, may provide satisfactory performance
in a wide range of real data applications in the biomedical sciences.
Besides the multinomial logistic regression model, we have also experimented with the support vector
machine as an alternative classifier and found its performance to be comparable with that of multinomial
logistic regression in simulations. Code implementing such analyses is available at the first author’s website
mentioned earlier. An advantage of logistic regression beyond classification is that the coefficients may be
easily interpreted and yield insight into the markers’ effects on the response. Another observation is that
the sampling behavior of NRI and IDI estimates seems less stable for the support vector machine when the
sample size is small.
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It is important to note that the evaluation of the NRI and the IDI must be based on correctly calibrated
models, especially when the old and new models are not nested. In numerical studies, we have observed
that the probability assessments from incorrectly calibrated non-nested models could be surprisingly dif-
ferent and that calculations based on such quantities may not yield reasonable results. That is, spurious
improvements in the NRI and the IDI may be achieved when either one or both of the models fit poorly.
In such scenarios, the improvements are confounded by the lack of fit of the models, potentially leading
to incorrect conclusions about the predictive values of added biomarkers. In general, careful consideration
of model calibration, including goodness-of-fit diagnostics, is needed to ensure adequate model fit prior
to model comparisons based on the NRI and the IDI.
SUPPLEMENTARY MATERIAL
Supplementary material is available at http://biostatistics.oxfordjournals.org.
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